Dr Mark Enea Montebello
Honorary Senior Lecturer

Dr Mark Enea Montebello

MB BS (UWA) FRANZCP FAChAM

Medicine & Health
National Drug&Alcohol Research

Summary -

Dr Mark Montebello is the Clinical Director and Senior Staff Specialist in Addiction Medicine and Psychiatry, at Drug and Alcohol Services, Northern Sydney Local Health District. He is the Accredited Medical Practitioner for the Royal North Shore Hospital Involuntary Drug and Alcohol Treatment Unit, Member of the Advisory Board of the Australian, New Zealand Journal of Psychiatry, a Honorary Senior Lecturer at the National Drug and Alcohol Research Centre, University of New South Wales, and a Clinical Senior Lecturer, Specialty of Addiction Medicine, Northern Clinical School, University of Sydney.

More information at https://orcid.org/0000-0002-1776-3974

Publications 2017 onwards -

Kwon I, Blazey A, Montebello M. The successful treatment of Kamini dependence with depot buprenorphine (Buvidal) – a case report. Australasian Psychiatry May 20 (2021). DOI: 10.1177/10398562211014214

Kwon I, Montebello M, Bittoun R. Tobacco dependence management in a smoke-free inpatient drug and alcohol unit. Australasian Psychiatry Dec 10 (2020) 1-9. https://doi.org/10.1177/1039856220975287

Grebely J, Read P, Cunningham E, Weltman M, Matthews G, Dunlop A, Montebello M, Martinello M, Gilliver R, Marks P, Applegate T, Dore G. Elbasvir and grazoprevir for hepatitis C virus genotype 1 infection in people with recent injecting drug use (DARLO-C): an open-label, single-arm, phase 4, multicentre trial. Health Sci Rep (2020) 3:e151. https://doi.org/10.1002/hsr2.151

Lintzeris N, Mills L, Dunlop A, Copeland J, McGregor I, Bruno R, Kirby A, Montebello M, Hall M, Jefferies M, Kevin R, Bhardwaj A. Cannabis use in patients 3 months after ceasing nabiximols for the treatment of cannabis dependence: Results from a placebo-controlled randomised trial. Drug and Alcohol Dependence 215 (2020) 18220. https://doi.org/10.1016/j.drugalcdep.2020.108220

Mills L, Lintzeris N, Bruno R, Montebello M, Dunlop A, Deacon R, Copeland J, Jefferies M, Rivas C, Mammen K. Validation of the Australian Treatment Outcomes Profile for use in clients with cannabis dependence. Drug and Alcohol Review (2020). DOI: 10.1111/dar.13050 

Jones NR, Shanahan M, Dobbins T, Degenhardt L, Montebello M, Gisev N, Larney S. Reductions in emergency department presentations associated with opioid agonist treatment vary by geographic location: A retrospective study in New South Wales, Australia. Drug and Alcohol Review (September 2019), 38, 690–698. DOI: 10.1111/dar.12976

Lintzeris N, Bhardwaj A, Mills L, Dunlop A, Copeland J, McGregor I, Bruno R, Gugusheff J, Phung N, Montebello M, Chan T, Kirby A, Hall M, Jefferies M, Luksza J, Shanahan M, Kevin R, Allsop D. Nabiximols for the Treatment of Cannabis Dependence: A Randomized Clinical Trial. JAMA Intern Med. doi:10.1001/jamainternmed.2019.1993

Jacobs NI, Montebello ME, Monds LA, Lintzeris N. Survey of Australian psychiatrists’ and psychiatry trainees’ knowledge about and attitudes towards medicinal cannabinoids. Australasian Psychiatry (2018) Oct 9: https://doi.org/10.1177/1039856218803675

Lintzeris N, Monds LA, Rivas C, Leung S, Dunlop A, Newcombe D, Walters C, Galea S, White N, Montebello ME, Demirkol A, Swanson N, and Ali R. Transferring Patients From Methadone to Buprenorphine: The Feasibility and Evaluation of Practice Guidelines. J Addict Med (2018) 12: 234–240

Bhardwaj AK, Allsop DJ, Copeland J, McGregor IS, Dunlop A, Shanahan M, Bruno R, Phung N, Montebello ME, Sadler C, Gugusheff J, Jackson M, Luksza J, Lintzeris N and Agonist Replacement for Cannabis Dependence (ARCD) study group. Randomised Controlled Trial (RCT) of cannabinoid replacement therapy (Nabiximols) for the management of treatment-resistant cannabis dependent patients: a study protocol. BMC Psychiatry (2018) 18:140

Allsop DJ, Rooney K, Arnold JC, Bhardwaj AK, Bruno R, Bartlett DJ, Montebello ME, Arkell T, Richards E, Gugusheff J, Rooke S, Kerley W, Murnion B, Haber P, McGregor IS, Lintzeris N. Randomised controlled trial (RCT) of daily aerobic exercise for inpatient cannabis withdrawal: A study protocol. Mental Health and Physical Activity 13 (2017) 57-67

Broad Research Areas:

Drug Related Harm / Addiction, Psychiatry, Medical Education

Qualifications:
MB BS (UWA), FRANZCP, FAChAM

Specific Research Keywords:
Addiction psychiatry, addiction medicine, cannabis, amphetamines, smoking cessation

Phone
61294629011
Location
Royal North Shore Hospital Community Health Centre Level 1, 2C Herbert Street St Leonards, New South Wales, 2065 Australia

Publications

  • Journal articles | 2021
    Dr Mark Enea Montebello
    Kwon I; Blazey A; Montebello M, 2021, 'The successful treatment of Kamini dependence with depot buprenorphine (Buvidal) - a case report.', Australas Psychiatry, pp. 10398562211014214, http://dx.doi.org/10.1177/10398562211014214
    Journal articles | 2021
    Dr Mark Enea Montebello
    Kwon I; Montebello M; Bittoun R, 2021, 'Tobacco dependence management in a smoke-free inpatient drug and alcohol unit.', Australas Psychiatry, vol. 29, pp. 14 - 21, http://dx.doi.org/10.1177/1039856220975287
    Journal articles | 2020
    Dr Mark Enea Montebello
    Grebely J; Read P; Cunningham EB; Weltman M; Matthews GV; Dunlop A; Montebello M; Martinello M; Gilliver R; Marks P; Applegate TL; Dore GJ, 2020, 'Elbasvir and grazoprevir for hepatitis C virus genotype 1 infection in people with recent injecting drug use (DARLO-C): An open-label, single-arm, phase 4, multicentre trial', Health Science Reports, vol. 3, pp. e151, http://dx.doi.org/10.1002/hsr2.151
    Journal articles | 2020
    Dr Mark Enea Montebello
    Mills L; Lintzeris N; Bruno R; Montebello M; Dunlop A; Deacon RM; Copeland J; Jefferies M; Rivas C; Mammen K, 2020, 'Validation of the Australian Treatment Outcomes Profile for use in clients with cannabis dependence', Drug and Alcohol Review, vol. 39, pp. 356 - 364, http://dx.doi.org/10.1111/dar.13050
    Journal articles | 2020
    Dr Mark Enea Montebello
    Lintzeris N; Mills L; Dunlop A; Copeland J; Mcgregor I; Bruno R; Kirby A; Montebello M; Hall M; Jefferies M; Kevin R; Bhardwaj A, 2020, 'Cannabis use in patients 3 months after ceasing nabiximols for the treatment of cannabis dependence: Results from a placebo-controlled randomised trial', Drug and Alcohol Dependence, vol. 215, http://dx.doi.org/10.1016/j.drugalcdep.2020.108220
    Journal articles | 2019
    Dr Mark Enea Montebello
    Lintzeris N; Bhardwaj A; Mills L; Dunlop A; Copeland J; McGregor I; Bruno R; Gugusheff J; Phung N; Montebello M; Chan T; Kirby A; Hall M; Jefferies M; Luksza J; Shanahan M; Kevin R; Allsop D, 2019, 'Nabiximols for the Treatment of Cannabis Dependence: A Randomized Clinical Trial', JAMA Internal Medicine, vol. 179, pp. 1242 - 1253, http://dx.doi.org/10.1001/jamainternmed.2019.1993
    Journal articles | 2019
    Dr Mark Enea Montebello
    Jones NR; Shanahan M; Dobbins T; Degenhardt L; Montebello M; Gisev N; Larney S, 2019, 'Reductions in emergency department presentations associated with opioid agonist treatment vary by geographic location: A retrospective study in New South Wales, Australia', Drug and Alcohol Review, vol. 38, pp. 690 - 698, http://dx.doi.org/10.1111/dar.12976
    Journal articles | 2019
    Dr Mark Enea Montebello
    Jacobs NI; Montebello M; Monds LA; Lintzeris N, 2019, 'Survey of Australian psychiatrists’ and psychiatry trainees’ knowledge about and attitudes towards medicinal cannabinoids', Australasian Psychiatry, vol. 27, pp. 80 - 85, http://dx.doi.org/10.1177/1039856218803675
    Journal articles | 2018
    Dr Mark Enea Montebello
    Lintzeris N; Monds LA; Rivas C; Leung S; Dunlop A; Newcombe D; Walters C; Galea S; White N; Montebello M; Demirkol A; Swanson N; Ali R, 2018, 'Transferring Patients from Methadone to Buprenorphine: The Feasibility and Evaluation of Practice Guidelines', Journal of Addiction Medicine, vol. 12, pp. 234 - 240, http://dx.doi.org/10.1097/ADM.0000000000000396
    Journal articles | 2018
    Dr Mark Enea Montebello
    Bhardwaj AK; Allsop DJ; Copeland J; McGregor IS; Dunlop A; Shanahan M; Bruno R; Phung N; Montebello M; Sadler C; Gugusheff J; Jackson M; Luksza J; Lintzeris N; Hall M; Hazelwood S; Winmill A; Chan T; Dojcinovic R; Jago B; McKendrick L; Rivas C; Schwanz R; Yang A; Zavareh Z; Barbaro A; Black K; Ho T; Jefferies M; Jule JC; Nagubandi S; Shahidi M; Lisa Snell CS; Wijanto M, 2018, 'Randomised Controlled Trial (RCT) of cannabinoid replacement therapy (Nabiximols) for the management of treatment-resistant cannabis dependent patients: A study protocol', BMC Psychiatry, vol. 18, http://dx.doi.org/10.1186/s12888-018-1682-2
    Journal articles | 2017
    Dr Mark Enea Montebello
    Allsop DJ; Rooney K; Arnold JC; Bhardwaj AK; Bruno R; Bartlett DJ; Montebello M; Arkell T; Richards E; Gugusheff J; Rooke S; Kerley W; Murnion B; Haber P; McGregor IS; Lintzeris N, 2017, 'Randomised controlled trial (RCT) of daily aerobic exercise for inpatient cannabis withdrawal: A study protocol', Mental Health and Physical Activity, vol. 13, pp. 57 - 67, http://dx.doi.org/10.1016/j.mhpa.2017.06.002
    Journal articles | 2015
    Dr Mark Enea Montebello
    Montebello ME; Brett B, 2015, 'Misuse and associated harms of quetiapine and other atypical antipsychotics', Current Topics in Behavioral Neurosciences, vol. 34, pp. 1 - 15, http://dx.doi.org/10.1007/7854_2015_424
    Journal articles | 2014
    Dr Mark Enea Montebello
    Allsop DJ; Copeland J; Lintzeris N; Dunlop AJ; Montebello M; Sadler C; Rivas GR; Holland RM; Muhleisen P; Norberg MM; Booth J; McGregor IS, 2014, 'Nabiximols as an agonist replacement therapy during cannabis withdrawal:A randomized clinical trial', JAMA Psychiatry, vol. 71, pp. 281 - 291, http://dx.doi.org/10.1001/jamapsychiatry.2013.3947
    Journal articles | 2014
    Dr Mark Enea Montebello
    Bruno R; Allsop DJ; Copeland J; Lintzeris N; McGregor I; Norberg M; Dunlop A; Montebello M; Sadler C; Holland R; Rivas G, 2014, 'The impact of Sativex® on cognitive function during treatment for cannabis withdrawal', Drug and Alcohol Dependence, vol. 140, pp. e22 - e22, http://dx.doi.org/10.1016/j.drugalcdep.2014.02.082
    Journal articles | 2013
    Dr Mark Enea Montebello
    Wong A; Montebello ME; Norberg MM; Rooney K; Lintzeris N; Bruno R; Booth J; Arnold JC; Mcgregor I, 2013, 'Exercise increases plasma THC concentrations in regular cannabis users', Drug and Alcohol Dependence, vol. 133, pp. 763 - 767, http://dx.doi.org/10.1016/j.drugalcdep.2013.07.031
    Journal articles | 2013
    Dr Mark Enea Montebello
    Montebello ME; Mendelsohn C, 2013, 'Smokers with mental illness: breaking down the myths', Medicine Today, vol. 14, pp. 53 - 56, http://www.medicinetoday.com.au/2013/august/article/smokers-mental-illness-breaking-down-myths
    Journal articles | 2009
    Dr Mark Enea Montebello
    Frewen AR; Baillie AJ; Montebello ME, 2009, 'Are cannabis users who participate in a randomized clinical trial different from other treatment seekers?', Journal of Substance Abuse Treatment, vol. 36, pp. 339 - 344, http://dx.doi.org/10.1016/j.jsat.2008.07.004
    Journal articles | 2008
    Dr Mark Enea Montebello
    Cruickshank C; Montebello ME; Dyer K; Quigley A; Blaszczyk J; Tomkins S; Shand D, 2008, 'A placebo-controlled trial of mirtazapine for the management of methamphetamine withdrawal', Drug and Alcohol Review, vol. 27, pp. 326 - 333, http://dx.doi.org/10.1080/09595230801935672

Awards

 

Winner of the NSLHD Quality and Research Awards - Keeping People Healthy award category

Winner of the 2019 Australasian Professional Society on Alcohol and other Drugs (APSAD) Clinician of the Year

Winner of the Journal of Addiction Medicine Most Downloaded Article Published in 2018 for “Transferring Patients from Methadone to Buprenorphine: The Feasibility and Evaluation of Practice Guidelines.”

Winner of the 1990 University of Western Australia Neuromuscular Disease Research Institute Medical Student Neuropathology Prize

Grants

See research activities above

Media